J&J executives have said they expect the therapy, Inlexzo, to become a future blockbuster and generate sales that ...

The U.S. Food and Drug Administration has approved Johnson & Johnson's drug delivery system for a type of bladder cancer, ...

The FDA approved Johnson & Johnson's Inlexzo, offering a new bladder cancer treatment option with high response rates for ...

In response to what it says is "deceptive" pharmaceutical advertising, the FDA sent out "100 cease-and-desist letters" to brands - a move that could have massive impact on pharma's $7 billion U.S.

Johnson & Johnson received Food and Drug Administration approval for Inlexzo, a treatment for people with bladder cancer.

The FDA has approved Inlexzo for adults with BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ.

Big Pharma faces tariff risks, patent cliffs, and regulatory pressure, but innovation and strong pipelines keep Eli Lilly, ...

An independent advisory panel of infectious disease experts, doctors and scientists voted unanimously to recommend the COVID-19 vaccine from Johnson & Johnson for emergency use authorization from the ...

These ads have been important for both TV companies and drugmakers. According to the U.S. Department of Health and Human ...

The FDA has sent warning letters to three formula companies, red-flagging concerns about serious quality control issues at some manufacturing facilities. The warning letters were all sent Wednesday to ...

The U.S. Food and Drug Administration has approved Johnson & Johnson's drug delivery system for patients with a type of ...